|
Market Closed -
Nasdaq
04:00:00 21/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 85.74 USD | -0.28% |
|
-0.21% | +29.18% |
Company Valuation: DexCom, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 52,042 | 43,740 | 47,945 | 30,377 | 25,885 | 32,445 | - | - |
| Change | - | -15.95% | 9.61% | -36.64% | -14.79% | 25.34% | - | - |
| Enterprise Value (EV) 1 | 52,692 | 45,068 | 49,813 | 31,073 | 26,209 | 31,684 | 31,384 | 30,569 |
| Change | - | -14.47% | 10.53% | -37.62% | -15.65% | 20.89% | -0.95% | -2.6% |
| P/E | 346x | 138x | 95.5x | 54.8x | 31.8x | 34.5x | 29.1x | 24.1x |
| PBR | 23.1x | 20.5x | 23.1x | 15.1x | 9.3x | 11.4x | 9.51x | 7.32x |
| PEG | - | 1x | 1.6x | 5.94x | 0.7x | 1.8x | 1.6x | 1.2x |
| Capitalization / Revenue | 21.3x | 15x | 13.2x | 7.53x | 5.55x | 6.2x | 5.6x | 5.03x |
| EV / Revenue | 21.5x | 15.5x | 13.8x | 7.7x | 5.62x | 6.06x | 5.42x | 4.74x |
| EV / EBITDA | 111x | 60x | 49.1x | 28.1x | 19.4x | 19x | 16.4x | 13.9x |
| EV / EBIT | 142x | 92.9x | 69.3x | 41x | 27x | 25.4x | 21.7x | 17.8x |
| EV / FCF | 989x | 148x | 97.3x | 49.3x | 24.3x | 31x | 25.7x | 20.8x |
| FCF Yield | 0.1% | 0.68% | 1.03% | 2.03% | 4.11% | 3.22% | 3.89% | 4.81% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 0.3875 | 0.82 | 1.3 | 1.42 | 2.09 | 2.489 | 2.952 | 3.562 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,448 | 2,910 | 3,622 | 4,033 | 4,662 | 5,229 | 5,793 | 6,446 |
| EBITDA 1 | 472.7 | 751.6 | 1,014 | 1,105 | 1,349 | 1,666 | 1,918 | 2,203 |
| EBIT 1 | 370.7 | 485.1 | 718.6 | 757.1 | 969.3 | 1,248 | 1,444 | 1,714 |
| Net income 1 | 154.7 | 341.2 | 541.5 | 576.2 | 836.3 | 973.1 | 1,146 | 1,401 |
| Net Debt 1 | 650.1 | 1,328 | 1,868 | 695.9 | 323.2 | -761.1 | -1,061 | -1,877 |
| Reference price 2 | 134.24 | 113.24 | 124.09 | 77.77 | 66.37 | 85.98 | 85.98 | 85.98 |
| Nbr of stocks (in thousands) | 387,688 | 386,258 | 386,374 | 390,595 | 390,016 | 377,361 | - | - |
| Announcement Date | 10/2/22 | 9/2/23 | 8/2/24 | 13/2/25 | 12/2/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 34.55x | 6.06x | 19.02x | -.--% | 32.45B | |
| 30.7x | 4.06x | 15.71x | 2.44% | 180B | |
| 19.83x | 3.46x | 12.37x | 3.06% | 114B | |
| 23.23x | 4.55x | 15.85x | 1.21% | 114B | |
| 26.93x | 2.64x | 10.6x | 2.68% | 78.39B | |
| 18.65x | 0.21x | 13.46x | 0.7% | 64.88B | |
| 31.09x | 7.72x | 19.92x | 1.28% | 54.02B | |
| 36.76x | 3.52x | 12.05x | 2.06% | 51.96B | |
| 37.64x | 9.35x | 26.14x | -.--% | 43.79B | |
| 38.33x | 3.11x | 11.6x | 0.56% | 31.94B | |
| Average | 29.77x | 4.47x | 15.67x | 1.4% | 76.53B | |
| Weighted average by Cap. | 27.88x | 4.14x | 15.14x | 1.8% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- DXCM Stock
- Valuation DexCom, Inc.
Select your edition
All financial news and data tailored to specific country editions
